These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5585388)

  • 21. [Oral galactose tolerance test. Diagnostic criteria and biological deviation in healthy persons and patients with liver diseases].
    Rommel K; Grimmel K
    Med Klin; 1966 Nov; 61(44):1735-8. PubMed ID: 5989738
    [No Abstract]   [Full Text] [Related]  

  • 22. An intravenous galactose tolerance test with an enzymatic determination of galactose. A comparison with other diagnostic aids in hepatobiliary diseases.
    Tengström B
    Scand J Clin Lab Invest Suppl; 1966; 18():132-42. PubMed ID: 5958513
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the problem of the assimilation coefficient based on the results of the intravenous glucose and galactose tolerance test].
    Förster H; Haslbeck M; Mehnert H
    Verh Dtsch Ges Inn Med; 1968; 74():934-9. PubMed ID: 5714452
    [No Abstract]   [Full Text] [Related]  

  • 24. [Description of a new galactose test by venous approach for hepatic function testing].
    Charbonnier A; Nepveux P; Fluteau D
    Lille Med; 1973 Mar; 18(3):312-5. PubMed ID: 4727500
    [No Abstract]   [Full Text] [Related]  

  • 25. [Determination of galactose eliminating capacity after intravenous administration--a liver function test].
    Kupcová V; Turecký L; Brixová E
    Vnitr Lek; 1992 Oct; 38(10):992-9. PubMed ID: 1481380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative evaluation of tolerance tests with sulfobromophthalein and with galactose in chronic liver diseases. (Value and limitations of the discriminating analyses used in the 2 tests for diagnosis of hepatic cirrhosis)].
    Coltorti M; Di Simone A; Budillon G; Carrella M; Oriani G
    Policlinico Med; 1968; 75(4):189-215. PubMed ID: 5708459
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on healthy subjects and patients with liver diseases following intravenous and oral galactose loading].
    Förster H; Haslbeck M; Mehnert H
    Verh Dtsch Ges Inn Med; 1967; 73():245-50. PubMed ID: 5591757
    [No Abstract]   [Full Text] [Related]  

  • 28. Galactose elimination as a liver function test in goats.
    Treacher RJ
    Res Vet Sci; 1972 Sep; 13(5):427-30. PubMed ID: 4635114
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of hepatic parenchymatous function. Contribution of the galactose clearance test. Study by multidimensional statistical analysis].
    Hecht Y; Ben Amar A; Touboul JP; el-Guedry H; Salmon D; Nakache JP
    Nouv Presse Med; 1972 Dec; 1(46):3133-4. PubMed ID: 4650517
    [No Abstract]   [Full Text] [Related]  

  • 30. [Analysis of the hepatic reserve by the liver tolerance tests].
    Takezaki E; Tsubokura T; Nakanishi T; Kawakami H
    Rinsho Byori; 1984 Jun; 32(6):577-83. PubMed ID: 6492415
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats.
    Young TH; Tang HS; Lee HS; Hsiong CH; Hu OY
    Metabolism; 2007 Sep; 56(9):1265-9. PubMed ID: 17697871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of intravenous and peroral galactose elimination tests with and without ethanol in different clinical conditions.
    Kesäniemi YA; Kurppa KO; Salaspuro MP
    Scand J Gastroenterol; 1973; 8(7):593-8. PubMed ID: 4768306
    [No Abstract]   [Full Text] [Related]  

  • 33. [Galactose loading test].
    Nakamura S; Tokita K; Kera K; Sasaki K
    Nihon Rinsho; 1970 Nov; 28(11):2639-44. PubMed ID: 5529786
    [No Abstract]   [Full Text] [Related]  

  • 34. Galactose retention: an alternative to the bromsulphthalein test.
    Sinniah D
    Singapore Med J; 1974 Dec; 15(4):273-5. PubMed ID: 4458070
    [No Abstract]   [Full Text] [Related]  

  • 35. [Re-evaluation of galactose tolerance test in clinical diagnosis].
    Kaneda E; Nagai S; Misugi Y; Yamaguchi H; Nakano Y
    Rinsho Byori; 1974 Oct; 22(10 Suppl):158. PubMed ID: 4475767
    [No Abstract]   [Full Text] [Related]  

  • 36. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.
    Mion F; Queneau PE; Rousseau M; Brazier JL; Paliard P; Minaire Y
    Hepatogastroenterology; 1995; 42(6):931-8. PubMed ID: 8847048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Disorders of liver function in endemic nephropathy].
    Milev B
    Z Gesamte Inn Med; 1972 Jul; 27(14):601-5. PubMed ID: 5082874
    [No Abstract]   [Full Text] [Related]  

  • 38. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.
    Holtmeier J; Leuschner M; Schneider A; Leuschner U; Caspary WF; Braden B
    Scand J Gastroenterol; 2006 Nov; 41(11):1336-41. PubMed ID: 17060128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 13C-breath tests in hepatology (cytosolic liver function).
    Perri F; Marras RM; Ricciardi R; Quitadamo M; Andriulli A
    Eur Rev Med Pharmacol Sci; 2004; 8(1):47-9. PubMed ID: 15209154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Galactose tolerance test and double glaucagon test].
    Verhaegen H; De Beukelaar A; Krug F; Verhaegen-Declercq ML
    Tijdschr Gastroenterol; 1970; 13(5):380-7. PubMed ID: 5512730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.